Author

Manuel Luque-Perez

Consejo Superior de Investigaciones Científicas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andres Joaquin Lopez-ContrerasiD· 1 shared Elena PietriniiD· 1 shared Ivan RosadoiD· 1 shared Lucía Simón-CarrascoiD· 1 shared Marta del Rio OlivaiD· 1 shared Soledad Raya· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andres Joaquin Lopez-ContrerasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PROTAC-Driven Protective Therapy increases the therapeutic window of anticancer drugs

Lucía Simón-Carrasco, Soledad Raya, Elena Pietrini, Manuel Luque-Perez, Marta del Rio Oliva, Ivan Rosado, Andres Joaquin Lopez-Contreras

This paper introduces PROTAC-Driven Protective Therapy (PDPT) to reduce toxicity of anticancer drugs by degrading proteins involved in drug-induced toxicity, showing protection of healthy cells and efficacy in TP53-mutant cancers.

bioRxiv · Jan 13, 2026 · PreprintCancer Biology